Automated Author ProfileKrimm, Isabelle
CRCL, Echappement tumoral, résistance et immunité, Rockfeller, 69008 Lyon, France
Krimm, Isabelle
Current S-Index
Sum of Dataset Indices for all datasets
Average Dataset Index per Dataset
Average Dataset Index per dataset
Total Datasets
Total datasets for this author
Average FAIR Score
Average FAIR Score per dataset
Total Citations
Total citations to the author's datasets
Total Mentions
Total mentions of the author's datasets
S-Index Interpretation
The S-Index (Sharing Index) is a comprehensive metric that represents the cumulative impact of all your datasets. It is calculated as the sum of Dataset Index scores across all your claimed datasets.
What it means:
- A higher S-index indicates greater overall impact of your datasets relative to typical datasets in their fields of research
- The S-Index grows as you add more datasets or as existing datasets gain more citations and mentions
- It provides a single number to track your research data impact over time
Current S-Index: 0.0 (sum of 4 datasets Dataset Index scores)
More information here.
S-Index Over Time
Cumulative Citations Over Time
Cumulative Mentions Over Time
Datasets
The BAG of Montpellier gathers researchers from distinct institutes (CBS, IGF, IRIM and LPHI) affiliated to the INSERM, the CNRS and the university ofMontpellier....
Authors
- Blaise, Mickael ;
- Bourguet, William ;
- Carivenc, Coralie ;
- Donnier, Elsa ;
- Gelin, Muriel ;
- Guichou, Jean-Francois ;
- Hoh, Francois ;
- Krimm, Isabelle ;
- Labesse, Gilles ;
- Le Maire, Albane ;
- Lionne, Corinne ;
- Mallet, Manon ;
- Tomaszczyk, Mathilde
The BAG of Montpellier gathers researchers from distinct institutes (CBS, IGF, IRIM and LPHI) affiliated to the INSERM, the CNRS and the university of Montpellier. The CBS is a node of the national infrastructure FRISBI. In this context, it is developping new methodologies for efficient ligand screening by X-ray diffraction. It is also involved in solving the structure of novel therapeutic targets to develop novel drug candidates. The IGF is involved in characterizing membrane proteins (mainly GPCRs) in order to better understand their functioning for therapeutic application. The IRIM and LPHI are focusing on several therapeutic targets related to infectious diseases in order to identify and develop novel inhibitors.
Authors
- Allemand, Frederic ;
- Blaise, Mickael ;
- Bourguet, William ;
- Carivenc, Coralie ;
- Delfosse, Vanessa ;
- Donnier, Elsa ;
- Gelin, Muriel ;
- Guichou, Jean-Francois ;
- Hoh, Francois ;
- Krimm, Isabelle ;
- Labesse, Gilles ;
- Le Maire, Albane ;
- Lionne, Corinne ;
- Mallet, Manon ;
- Moreno Barbosa, Glauce ;
- Sibille, Nathalie ;
- Tambones, Izabella
The BAG of Montpellier gathers researchers from distinct institutes (CBS, IGF, IRIM and LPHI) affiliated to the INSERM, the CNRS and the university of Montpellier. The CBS is a node of the national infrastructure FRISBI. In this context, it is developping new methodologies for efficient ligand screening by X-ray diffraction. It is also involved in solving the structure of novel therapeutic targets to develop novel drug candidates. The IGF is involved in characterizing membrane proteins (mainly GPCRs) in order to better understand their functioning for therapeutic application. The IRIM and LPHI are focusing on several therapeutic targets related to infectious diseases in order to identify and develop novel inhibitors.
Authors
- Bourguet, William ;
- Delfosse, Vanessa ;
- Donnier, Elsa ;
- Gelin, Muriel ;
- Guesdon, Audrey ;
- Guichou, Jean-Francois ;
- Hoh, Francois ;
- Krimm, Isabelle ;
- Labesse, Gilles ;
- Le Maire, Albane ;
- Leyrat, Cedric ;
- Lionne, Corinne ;
- Mallet, Manon ;
- Sobron, Lua ;
- Tomaszczyk, Mathilde
The BAG of Montpellier gathers researchers from distinct institutes (CBS, IGF, IRIM and LPHI) affiliated to the INSERM, the CNRS and the university of Montpellier. The CBS is a node of the national infrastructure FRISBI. In this context, it is developping new methodologies for efficient ligand screening by X-ray diffraction. It is also involved in solving the structure of novel therapeutic targets to develop novel drug candidates. The IGF is involved in characterizing membrane proteins (mainly GPCRs) in order to better understand their functioning for therapeutic application. The IRIM and LPHI are focusing on several therapeutic targets related to infectious diseases in order to identify and develop novel inhibitors.
Authors
- Bourguet, William ;
- Delfosse, Vanessa ;
- Donnier, Elsa ;
- Gelin, Muriel ;
- Guichou, Jean-Francois ;
- Hoh, Francois ;
- Krimm, Isabelle ;
- Labesse, Gilles ;
- Le Maire, Albane ;
- Leyrat, Cedric ;
- Lionne, Corinne ;
- Mallet, Manon ;
- Sobron, Lua ;
- Tomaszczyk, Mathilde